Dr Nidhi Garg
NHMRC
Australia
Clinical phenotypes and novel neurophysiological and immunological biomarkers in inflammatory neuropathy and neurodegeneration
NHMRC
55,801
01/01/16
3.0
Motor neurone diseases
neuropathy | neurophysiology | neuroimmunology | neurodegenerative disorders | neuromuscular diseases
The aim of this project is to define subgroups of inflammatory neuropathies by correlating clinical phenotypes with immunological & neurophysiological profiles. The identification of specific autoantibody markers in patients with inflammatory neuropathies will aid in diagnosis &differentiation from motor neurodegenerative disorders. Identification of prognostic novel biomarkers that predict response to immunotherapy will be invaluable in the clinical setting & allow for better treatment planning